Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Percy Lee, M.D.
Percy Lee, M.D.

Specialty:

Radiation Oncology

General Information:

Gender:
Male
Language(s):
English, Mandarin

Affiliation(s):

Assistant Professor and Physician, Department of Radiation Oncology
Director, Stereotactic Body Radiation Therapy (SBRT) Program
Co-Director, CNS Stereotactic Radiosurgery (SRS) Program
Physician, Lung Cancer Program
Physician, Gastrointestinal Oncology Program
Physician, Kidney Cancer Program
Physician, Neuro-Oncology Program
Member, JCCC Cancer Molecular Imaging Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center
Santa Monica-UCLA Medical Center and Orthopaedic Hospital

Education:

Fellowship:
Radiation Oncology, Stanford University Medical Center, 2008
Residency:
Radiation Oncology, Stanford University Medical Center, 2004 - 2008
Internship:
Internal Medicine, Massachusetts General Hospital, 2003 - 2004
Medical Degree:
M.D., Harvard Medical School, 2003

Certification(s):

Board Certification(s):
Radiation Oncology, American Board of Radiology, 2009

Contact Information:

Phone:
(310) 825-9775 Radiation Oncology patient appointments and Stereotactic Body Radiation Therapy (SBRT) Program
(310) 825-9771 Radiation Oncology referring physician, academic support
(310) 825-4966 CNS Sterotactic Radiosurgery (SRS) patient appointments
(310) 794-7333 Lung Cancer Program information and patient referral
(310) 206-1446 Gastrointestinal Oncology information and patient referral
(310) 794-7788 Pancreatic Cancer Program information and patient referral
Email:
Website:

Practice Information:

Clinical Interest(s):
Lung Cancer
Cancers of the Digestive Tract
Hepatobiliary Cancers
Pancreatic Cancer
Kidney Cancers
Brain Tumors
Stereotactic Body Radiation Therapy (SBRT)
CNS Stereotactic Radiosurgery (SRS)
Image-guided Radiation Therapy (IGRT)
Intensity Modulated Radiation Therapy (IMRT)

Scientific Interest(s):

Dr. Percy Lee’s research interests are primarily translational. He has expertise in innovative approaches of delivering radiation therapy; these include intensity-modulated radiation therapy (IMRT), as well as stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) where highly focused radiation is concentrated on localized tumors. These approaches minimize radiation to surrounding normal tissue, thereby reducing side effects and improving tumor control. Lee is focused on developing novel functional image-guided radiation therapy approaches and discovering new molecularly targeted anti-angiogenic drugs for cancer therapy. In addition, he is investigating combining molecular targeted therapy with SBRT in a rational and innovative approach with the goal of improving treatment outcomes.

Selected Cancer-Related Publications:

Lee P, Bazan JG, Lavori PW, Weerasuriya DK, Quon A, Le QT, Wakelee HA, Graves EE, Loo BW. Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer. Clin Lung Cancer. 2012 Jan;13(1):52-8. Epub 2011 Jun 24

Zumsteg Z, Demarco J, Lee SP, Steinberg ML, Lin CS, McBride W, Lin K, Wang PC, Kupelian P, Lee P. Image guidance during head-and-neck cancer radiation therapy: analysis of alignment trends with in-room cone-beam computed tomography scans. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):712-9. Epub 2011 Nov 16

Evers P, Lee PP, DeMarco J, Agazaryan N, Sayre JW, Selch M, Pajonk F. Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma. BMC Cancer. 2010 Jul 21;10:384.

Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):328-33.

Lee P, Goishi K, Davidson AJ, Mannix R, Zon L, Klagsbrun M. Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10470-5. Epub 1969 Dec 31